CD14 and rheumatoid arthritis: While classical monocytes were suggested to play a significant role in the progression of several diseases, the trafficking of separately defined intermediate (CD14+ CD16+) and nonclassical (CD14low CD16++) monocytes during RA was not fully investigated.